-
Product Insights
Aortic Valve Diseases – Drugs In Development, 2023
Global Markets Direct’s, ‘Aortic Valve Diseases - Drugs In Development, 2023’, provides an overview of the Aortic Valve Diseases pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Diseases, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Ventricular Tachycardia – Drugs In Development, 2023
Global Markets Direct’s, ‘Ventricular Tachycardia - Drugs In Development, 2023’, provides an overview of the Ventricular Tachycardia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ventricular Tachycardia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Aortic Valve Stenosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Aortic Valve Stenosis - Drugs In Development, 2023’, provides an overview of the Aortic Valve Stenosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Aortic Valve Stenosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Arterial Thrombosis – Drugs In Development, 2023
Global Markets Direct’s, ‘Arterial Thrombosis - Drugs In Development, 2023’, provides an overview of the Arterial Thrombosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Arterial Thrombosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Congenital Heart Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Congenital Heart Disease - Drugs In Development, 2023’, provides an overview of the Congenital Heart Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Congenital Heart Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Endomyocardial (Eosinophilic) Disease – Drugs In Development, 2023
Global Markets Direct’s, ‘Endomyocardial (Eosinophilic) Disease - Drugs In Development, 2023’, provides an overview of the Endomyocardial (Eosinophilic) Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development for Endomyocardial (Eosinophilic) Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Cardiac Arrest – Drugs In Development, 2023
Global Markets Direct’s, ‘Cardiac Arrest - Drugs In Development, 2023’, provides an overview of the Cardiac Arrest pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cardiac Arrest, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Cerebral Infarction (Brain Infarction) – Drugs In Development, 2023
Global Markets Direct’s, ‘Cerebral Infarction (Brain Infarction) - Drugs In Development, 2023’, provides an overview of the Cerebral Infarction (Brain Infarction) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Cerebral Infarction (Brain Infarction), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Product Insights
Ischemic Cardiomyopathy – Drugs In Development, 2023
Global Markets Direct’s, ‘Ischemic Cardiomyopathy - Drugs In Development, 2023’, provides an overview of the Ischemic Cardiomyopathy pipeline landscape. The report provides comprehensive information on the therapeutics under development for Ischemic Cardiomyopathy, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) – Drugs In Development, 2023
Global Markets Direct’s, ‘Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) - Drugs In Development, 2023’, provides an overview of the Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Giant Cell Arteritis (Temporal Arteritis/Cranial Arteritis/Horton Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete...